Keywords: gilead, reports, 48-wk, data, hiv, study, sciences

Gilead reports 48-wk data from HIV study

Article | 14 February 2005

Print This

Gilead Sciences of the USA has reported 48-week data from study 934 indicating that a regimen of Truvada, which is comprised ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in